UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000006350
Receipt No. R000007516
Official scientific title of the study Preventive effect of aliskiren on migraine complicated with hypertension.
Date of disclosure of the study information 2011/09/16
Last modified on 2019/01/07 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Preventive effect of aliskiren on migraine complicated with hypertension.
Title of the study (Brief title) Anti-migraine effect of aliskiren
Region
Japan

Condition
Condition hypertension
migraine
Classification by specialty
Neurology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Renin-angiotensin modulators are known to possess an anti-migraine effect. The objective of the present study is to determine whether treatment with the direct renin inhibitor aliskiren is effective as a migraine-prophylactic drug.

Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes The number of days with migraine per month
Key secondary outcomes The number of headache attacks per month

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Administration of alisliren
Interventions/Control_2 Administration of candesartan
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria 1. Individuals with informed consent
2. Aged more than 18 years and below 65 years.
3. Hypertensive subjects who satisfy the diagnostic criteria of migraine according to ICHD-II and who have been keeping a headache diary more than one month before entry.
4. Individuals who have had migraine attacks (2-6 times) in the last three months.
5. Those who have moderate or severe hypertension.
Key exclusion criteria 1. Individuals taking an ACE inhibitor or ARB.
2. Those who fail to submit informed consent.
3. Those who may be allergic to aliskiren or candesartan.
4. SBP>180 mmHg or DBP>110 mmHg.
5. Those who are pregnant or hope to get pregnant.
6. Menstruation-related migraine patients.
7. Those who are taking cyclosporine.
8. Those who have severe hepatic dysfunction and/or renal dysfunction.
9. Those who are judged not to be eligible for entry to this study by their attending physician.
Target sample size 20

Research contact person
Name of lead principal investigator Mamoru Shibata
Organization School of Medicine, Keio University
Division name Department of Neurology
Address 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
TEL
Email

Public contact
Name of contact person
Organization School of Medicine, Keio University
Division name Department of Neurology
Address 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
TEL
Homepage URL
Email

Sponsor
Institute Department of Neurology, School of Medicine, Keio University
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2011 Year 09 Month 16 Day

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 09 Month 12 Day
Anticipated trial start date
2011 Year 09 Month 13 Day
Last follow-up date
2013 Year 09 Month 30 Day
Date of closure to data entry
2013 Year 09 Month 30 Day
Date trial data considered complete
2013 Year 09 Month 30 Day
Date analysis concluded
2013 Year 09 Month 30 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2011 Year 09 Month 15 Day
Last modified on
2019 Year 01 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007516